Notice2023-18288
Advisory Committee on Immunization Practices
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
August 25, 2023
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Abstract
In accordance with regulatory provisions, the Centers for Disease Control and Prevention (CDC) announces the following meeting of the Advisory Committee on Immunization Practices (ACIP). This meeting is open to the public. Time will be available for public comment.
Full Text
<html>
<head>
<title>Federal Register, Volume 88 Issue 164 (Friday, August 25, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 164 (Friday, August 25, 2023)]
[Notices]
[Pages 58277-58278]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-18288]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[Docket No. CDC-2023-0060]
Advisory Committee on Immunization Practices
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice and request for comment.
-----------------------------------------------------------------------
SUMMARY: In accordance with regulatory provisions, the Centers for
Disease Control and Prevention (CDC) announces the following meeting of
the Advisory Committee on Immunization Practices (ACIP). This meeting
is open to the public. Time will be available for public comment.
DATES: The meeting will be held on September 12, 2023, 10 a.m. to 4
p.m., EDT (date and times subject to change; see the ACIP website for
updates: <a href="https://www.cdc.gov/vaccines/acip/index.htm">https://www.cdc.gov/vaccines/acip/index.htm</a>).
Written comments will be received between August 25-September 8,
2023.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2023-
0060, by either of the methods listed below. CDC does not accept
comments by email.
<bullet> Federal eRulemaking Portal: <a href="https://www.regulations.gov">https://www.regulations.gov</a>.
Follow the instructions for submitting comments.
[[Page 58278]]
<bullet> Mail: Ms. Stephanie Thomas, ACIP Meeting, Centers for
Disease Control and Prevention, 1600 Clifton Road NE, Mailstop H24-8,
Atlanta, Georgia 30329-4027. Attn: Docket No. CDC-2023-0060.
Instructions: All submissions received must include the Agency name
and docket number. All relevant comments received in conformance with
the <a href="https://www.regulations.gov">https://www.regulations.gov</a> suitability policy will be posted
without change to <a href="https://www.regulations.gov">https://www.regulations.gov</a>, including any personal
information provided. For access to the docket to read background
documents or comments received, go to <a href="https://www.regulations.gov">https://www.regulations.gov</a>.
The meeting will be webcast live via the World Wide Web. The
webcast link can be found on the ACIP website at <a href="https://www.cdc.gov/vaccines/acip/index.html">https://www.cdc.gov/vaccines/acip/index.html</a>.
FOR FURTHER INFORMATION CONTACT: Ms. Stephanie Thomas, Committee
Management Specialist, Advisory Committee on Immunization Practices,
National Center for Immunization and Respiratory Diseases, Centers for
Disease Control and Prevention, 1600 Clifton Road NE, Mailstop H24-8,
Atlanta, Georgia 30329-4027. Telephone: (404) 639-8836; Email:
<a href="/cdn-cgi/l/email-protection#92d3d1dbc2d2f1f6f1bcf5fde4"><span class="__cf_email__" data-cfemail="3e7f7d776e7e5d5a5d10595148">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION:
Purpose: The Advisory Committee on Immunization Practices (ACIP) is
charged with advising the Director, Centers for Disease Control and
Prevention (CDC), on the use of immunizing agents. In addition, under
42 U.S.C. 1396s, the Committee is mandated to establish and
periodically review and, as appropriate, revise the list of vaccines
for administration to vaccine-eligible children through the Vaccines
For Children program, along with schedules regarding dosing interval,
dosage, and contraindications to administration of vaccines. Further,
under applicable provisions of the Affordable Care Act and section 2713
of the Public Health Service Act, immunization recommendations of ACIP
that have been approved by the Director, CDC, and appear on CDC
immunization schedules generally must be covered by applicable health
plans.
Matters To Be Considered: The agenda will include discussion of
COVID-19 vaccines. Recommendation votes for COVID-19 vaccines are
scheduled. Agenda items are subject to change as priorities dictate.
For more information on the meeting agenda, visit <a href="https://www.cdc.gov/vaccines/acip/meetings/index.html">https://www.cdc.gov/vaccines/acip/meetings/index.html</a>.
Meeting Information: The meeting will be webcast live via the World
Wide Web. For more information on ACIP, please visit the ACIP website:
<a href="https://www.cdc.gov/vaccines/acip/index.html">https://www.cdc.gov/vaccines/acip/index.html</a>.
Public Participation
Interested persons or organizations are invited to participate by
submitting written views, recommendations, and data. Please note that
comments received, including attachments and other supporting
materials, are part of the public record and are subject to public
disclosure. Comments will be posted on <a href="https://www.regulations.gov">https://www.regulations.gov</a>.
Therefore, do not include any information in your comment or supporting
materials that you consider confidential or inappropriate for public
disclosure. If you include your name, contact information, or other
information that identifies you in the body of your comments, that
information will be on public display. CDC will review all submissions
and may choose to redact, or withhold, submissions containing private
or proprietary information such as Social Security numbers, medical
information, inappropriate language, or duplicate/near-duplicate
examples of a mass-mail campaign. CDC will carefully consider all
comments submitted into the docket.
Written Public Comment: The docket will be opened to receive
written comments on August 25, 2023. Written comments must be received
by September 8, 2023.
Oral Public Comment: This meeting will include time for members of
the public to make an oral comment. Priority will be given to
individuals who submit a request to make an oral public comment before
the meeting according to the procedures below.
Procedure for Oral Public Comment: All persons interested in making
an oral public comment at the September 12, 2023, ACIP meeting must
submit a request at <a href="https://www.cdc.gov/vaccines/acip/meetings/index.html">https://www.cdc.gov/vaccines/acip/meetings/index.html</a> no later than 11:59 p.m., EDT, September 8, 2023, according
to the instructions provided.
If the number of persons requesting to speak is greater than can be
reasonably accommodated during the scheduled time, CDC will conduct a
lottery to determine the speakers for the scheduled public comment
session. CDC staff will notify individuals regarding their request to
speak by email on September 11, 2023. To accommodate the significant
interest in participation in the oral public comment session of ACIP
meetings, each speaker will be limited to three minutes, and each
speaker may only speak once per meeting.
The Director, Office of Strategic Business Initiatives, Office of
the Chief Operating Officer, Centers for Disease Control and
Prevention, has been delegated the authority to sign Federal Register
notices pertaining to announcements of meetings and other committee
management activities, for both the Centers for Disease Control and
Prevention and the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2023-18288 Filed 8-24-23; 8:45 am]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on August 25, 2023.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.